Phibro Animal Health PAHC
NASDAQ PAHC
$36.80 -0.51 (-1.37%)
As of: Sep 9, 2026 · 3:59 PM EDT

Phibro Animal Health (PAHC) Change in Accured Expenses (2013 - 2026)

Phibro Animal Health (PAHC) posted Change in Accured Expenses of $28.7 million for Q2 2026, up 7837.12% on a QoQ basis from $361000.0 in Q1 2026, and up 9.71% year-over-year from $26.1 million in Q2 2025.

Analysis

Phibro Animal Health (PAHC) Change in Accured Expenses (2013 - 2026) Analysis & Trends

Phibro Animal Health has reported Change in Accured Expenses for 14 years, with the latest figure at $28.7 million in Q2 2026.

  • On a quarterly basis, Change in Accured Expenses rose 9.71% year-over-year to $28.7 million in Q2 2026; TTM through Jun 2026 was $26.4 million, a 44.12% decrease from a year earlier, with the FY2026 full-year figure at $26.4 million, down 44.12% from the prior year.
  • Change in Accured Expenses was $28.7 million for Q2 2026 at Phibro Animal Health, up from $361000.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $28.7 million in Q2 2026, with the low at -$13.7 million in Q3 2025.
  • Average Change in Accured Expenses over 5 years is $4.7 million, with a median of $445500.0 recorded in 2024.
  • The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses surged 1357.99% in 2024, then sank 288.42% in 2025.
  • Over 5 years, Change in Accured Expenses stood at $6.0 million in 2022, then soared by 36.38% to $8.2 million in 2023, then jumped by 202.8% to $24.8 million in 2024, then plunged by 55.48% to $11.0 million in 2025, then jumped by 159.89% to $28.7 million in 2026.
  • The last three Change in Accured Expenses figures came in at $28.7 million (Q2 2026), $361000.0 (Q1 2026), and $11.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Idexx Laboratories 40.69 Bn 40.49 Bn 779.09 Mn -
2 Zoetis 30.63 Bn 28.95 Bn 1.05 Bn 142.00 Mn
3 Elanco Animal Health 11.77 Bn 11.24 Bn 798.00 Mn -
4 Phibro Animal Health 1.49 Bn 1.41 Bn 134.40 Mn 28.65 Mn
5 Immucell 90.19 Mn 81.33 Mn 2.44 Mn -
6 Zhengye Biotechnology Holding 76.23 Mn 69.14 Mn - -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 28.65 Mn
Mar 31, 2026 361,000.00
Dec 31, 2025 11.03 Mn
Sep 30, 2025 -13.69 Mn
Jun 30, 2025 26.12 Mn
Mar 31, 2025 -199,000.00
Dec 31, 2024 24.77 Mn
Sep 30, 2024 -3.52 Mn
Jun 30, 2024 9.28 Mn
Mar 31, 2024 530,000.00
Dec 31, 2023 8.18 Mn
Sep 30, 2023 -5.80 Mn
Jun 30, 2023 -738,000.00
Mar 31, 2023 -745,000.00
Dec 31, 2022 6.00 Mn
Sep 30, 2022 -10.26 Mn
Jun 30, 2022 -591,000.00
Mar 31, 2022 5.75 Mn
Dec 31, 2021 5.19 Mn
Sep 30, 2021 -7.20 Mn